Global Digital Pathology Market Segmentation, By Type (Human Pathology, Veterinary Pathology), Product (Artificial Intelligence, Scanners, Software, Communication Systems, Storage Systems), Application (Drug Discovery, Disease Diagnosis, Teleconsultation, Training and Education), End Users (Pharmaceutical and Biotechnology, Hospitals, Academic Research Institutes) – Industry Trends and Forecast to 2031
Digital Pathology Market Analysis
The use of this disruptive technology is on the verge of becoming standard of care in the field of pathology. Static images, live streaming images, and, most recently, whole slide imaging have all been used in digital pathology (WSI). Digital pathology devices or image analysis algorithms used in diagnostic reporting typically require regulatory approval such as FDA (USA) or CE IVD. Digital pathology and image analysis could improve the accuracy, reproducibility, and standardization of study inclusion criteria and outcomes.
Digital Pathology Market Size
Global digital pathology market size was valued at USD 1.22 billion in 2023 and is projected to reach USD 3.15 billion by 2031, with a CAGR of 12.5% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes
|
Digital Pathology Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Key Market Players
|
F. Hoffmann-La Roche Ltd (Switzerland), Hamamatsu Photonics (Japan), 3DHISTECH Ltd. (Hungary), AstraZeneca (U.K.), General Electric (U.S.), Healthcare Trading Co. LLC (UAE), Koninklijke Philips N.V (Netherlands), Inspirata, Inc. (U.S.), Olympus Corporation (Japan), Sectra AB (U.S.), PerkinElmer Inc. (U.S.), Apollo Enterprise Imaging Corp (U.S.), Mikroscan Technologies, Inc. (U.S.), VMscope GmbH (Germany), Huron Technologies International Inc. (Canada), Objective Pathology Services Limited (Canada), OptraScan (U.S.), Pathcore (Canada), Agfa-Gevaert Group (Belgium), Proscia Inc. (U.S.)
|
|
Market Opportunities
|
|
Digital Pathology Market Definition
Digital pathology is the practice of pathology that employs digital imaging. Digital pathology is the use of computer workstations to view digital whole slide images (WSIs) obtained from high resolution scanning of glass microscope slides applications include teaching, research and primary diagnostic reporting.
Digital Pathology Market Dynamics
Drivers
- Rapid Technological Advancements are Fostering the Market Growth
Rapid technological advancements in digital pathology systems are also expected to drive market expansion. Digital imaging, computerization, robotic light microscopy, and multiple fibre optic communications are all contributing to the expansion. Whole slide imaging is one such technique that has several advantages over conventional light microscopes and is expected to boost the market.
- Rising use of AI in Healthcare
The use of AI in healthcare is increasing, with a growing emphasis on improving patient care quality by incorporating AI into various aspects of healthcare services, such as pathological diagnosis. As a result, artificial intelligence (AI) provides smooth primary care flow and automation, allowing doctors to focus on more essential and horrific patients. Furthermore, AI solutions in the healthcare industry are becoming more humanized.
Opportunities
- Growing Preference for Computer-Aided Diagnosis
The growing preference for computer-aided diagnosis, which integrates image processing, physics, mathematics, and computing algorithms, enables efficient disease detection, and aids in the evaluation of anatomic structures of interest, as well as the quantification of disease progression and risk assessment, will drive market growth. Companies such as Olympus are providing a variety of tools for remote slide sharing and image processing, which is expected to drive market growth in the coming years. Leica Biosystems received FDA approval for the Aperio AT2 DX Scanner and Aperio WebViewer for remote diagnosis during the pandemic in April 2020. During this emergency, Phillips also received FDA approval for its IntelliSite Pathology Solution for remote diagnosis.
Restraints/Challenges
- High Cost of Digital Pathology
High cost of digital pathology and the low adoption rate in emerging and underdeveloped countries will obstruct the market's growth rate. Augmenting keeps the cost of digital pathology low by functioning as a modular hardware platform with integrated digital pathology software applications.
This digital pathology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the digital pathology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Digital Pathology Market
The COVID-19 pandemic had a significant impact on digital pathology services. Digital pathology has the potential to "protect clinical services and pathology-based research in the current and future climates. This digital-based diagnostic approach represents a new approach to evaluating surgical pathology slides from formalin-fixed paraffin-embedded tissue (FFPE). It liberates the pathologist from the constraints of working with an optical microscope in his or her office. At the same time, it can have an impact on pathologists “social interaction,' including their interactions with clinicians and even patients. At the peak of the COVID-19 pandemic, a recent contribution from our group briefly addressed the changing aspects of such a relationship.
Digital Pathology Market Scope
The digital pathology market is segmented on the basis of type, product, application and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Human Pathology
- Veterinary Pathology
Product
- Scanners
- Brightfield
- Other Scanners
- Software
- Integrated software
- Standalone software
- Storage Solution
Application
- Drug Discovery
- Disease Diagnosis
- Training and Education
End users
- Academic and Research Institutes
- Hospitals and Reference Laboratories
- Pharmaceutical and Biotechnology Companies
Digital Pathology Market Regional Analysis
The digital pathology market is analyzed and market size insights and trends are provided by country, type, product, application and end users as referenced above.
The countries covered in the digital pathology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the digital pathology market due to introduction of favorable reimbursement policies and the implementation of favorable initiatives by the government in the U.S. and Canada.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2024 to 2031 owing to the rising prevalence of cancer diseases in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Digital Pathology Market Share
The digital pathology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to digital pathology market.
Digital Pathology Market Leaders Operating in the Market Are:
- F. Hoffmann-La Roche Ltd (Switzerland)
- Hamamatsu Photonics (Japan)
- 3DHISTECH Ltd. (Hungary)
- AstraZeneca (U.K.)
- General Electric (U.S.)
- Healthcare Trading Co. LLC (UAE)
- Koninklijke Philips N.V (Netherlands)
- Inspirata, Inc. (U.S.)
- Olympus Corporation (Japan)
- Sectra AB (U.S.), PerkinElmer Inc. (U.S.)
- Apollo Enterprise Imaging Corp (U.S.)
- Mikroscan Technologies, Inc. (U.S.)
- VMscope GmbH (Germany)
- Huron Technologies International Inc. (Canada)
- Objective Pathology Services Limited (Canada)
- OptraScan (U.S.)
- Pathcore (Canada)
- Agfa-Gevaert Group (Belgium)
- Proscia Inc. (U.S.)
Latest Developments in Digital Pathology Market
- In September 2021, Visiopharm (Denmark) and Agilent Technologies, Inc. (US) collaborated to co-market Visiopharm's portfolio of CE-IVD marked AI-driven Precision Pathology software and Agilent's portfolio of automated pathology staining solutions. Based on a shared vision of end-to-end quality and standardisation of tissue diagnostics, the alliance will address the unmet needs of pathology laboratories around the world. The companies' shared goal is to create technology, products, and services that will improve pathology lab uniformity and speed up correct diagnosis
- In April 2021, OptraSCAN will introduced OS-Ultra 320 high-speed scanners. The device is designed to scan cells/tissues 15x15 mm in size at 40x magnification in 60 seconds. Furthermore, the widespread use of scanners in pathology labs is propelling market growth
SKU-